Velcade bortezomib: Phase II data

Data from a Canadian Phase II trial in 28 evaluable patients with

Read the full 125 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE